ghk cu kidney NL-GHK-Cu – protection against heart, eye, and brain diseases – Synthagen PL GHK-Cu Injectable - Team Wellcore

The Bioavailability of Drugs-The Current State of Knowledge

Store all vials at -20C, protected from light and moisture, for long-term stability

GHK-Cu also demonstrates chemoattractant properties, recruiting immune cells, fibroblasts, and other repair cells to sites of injury where they are needed

Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly

Riboflavin (B2) contributes to the protection of cells from oxidative stress and the maintenance of normal vision

Directions: Preparation: Reconstitute the contents of the vial with the supplied bacteriostatic water before use, following the exact amount as per the physician's guidelines